Auregen BioTherapeutics SA

AUREGEN BIOTHERAPEUTICS

3D printing services; 3D printing services, namely, customized creation of three-dimensional parts using rapid prototyping equipment; 3D biological printing services; biological 3D printing services;Laboratory apparatus for the manufacture of living tissue and three-dimensional organs, namely, incubators and cell culture apparatus for laboratory use for the manufacture of living tissue and three dimensional organs; laboratory apparatus specially adapted for scientific research performed in laboratories for the manufacture of living tissue and three dimensional organs; bioreactors for cell culture; print heads for ink-jet printers; laboratory equipment for scientific use and research, namely, systems comprising a liquid distributor, an imaging facility being medical imaging equipment, related control software, and related analysis software, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment;Biological implants, namely, a vital processed human or animal connective tissue; biological tissue for implantation; cells for medical use; human tissue for allografts; living cells for medical use; implants comprised of living tissue for guided tissue regeneration; implants comprising living tissue; implantable materials comprised of living tissue for use in guided tissue regeneration; skin grafts; surgical implants composed of living tissue; vascular grafts being living tissue; biological molecules to assist with the development of tissue, namely, peptides, polypeptides, nucleosides, amino acids; natural biomaterials for bone and tissue augmentation for medical use; natural biomaterials for bone filling for medical purposes; natural biomaterials for filling cartilage for medical purposes; surgical implants comprising living tissues; biological tissue cultures for medical purposes, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment;AUREGEN BIO THERAPEUTICS;Medical services in the field of cellular immunotherapy and transplant, excluding services used for a diagnosis; human cell and tissue bank services; medical services regarding the collection and preservation of cells for medical use, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment;BIOTHERAPEUTICS;Technical research in the field of biomaterials, 3D bioprinting and tissue engineering; three-dimensional biological printing research; tissue engineering research; scientific and medical research and development in the field of bioprinting; research and development of 3D processes and technology; scientific services relating to the isolation and cultivation of human tissues and cells, excluding services used for a diagnosis; scientific and medical research and development in the field of the manufacture of tissue; development and culture of artificial tissue and cells in the nature of tissue engineering; tissue engineering services; industrial analysis and research services in the field of tissue engineering, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment;

AUREGEN BIOTHERAPEUTICS

3D printing services; renting of 3D printers; creation of customized three-dimensional shaped parts using rapid prototyping equipment; 3D bioprinting; bioprinting;Laboratory apparatus for fabrication of three-dimensional tissues and organs; biochips for the production of three-dimensional living tissues and organs; bioreactor for cell culturing; bioreactors for laboratory use; bioreactors for research use; cell culture apparatus for laboratory use, namely, cell culture dishes, tissue culture flasks; imaging devices for use in research on biomaterials adapted and used for printing three- dimensional objects for the creation of prosthetic limbs and grafts; laboratory apparatus and instruments for use in research on biomaterials adapted and used for printing three-dimensional objects for the creation of prosthetic limbs and grafts; print heads for inkjet printers; scientific research and laboratory apparatus and instruments for research on biomaterials adapted and used for printing three-dimensional objects for the creation of prosthetic limbs and grafts in the field of cytology; laboratory apparatus and instruments for research on biomaterials adapted and used for printing three-dimensional objects for the creation of prosthetic limbs and grafts for use in biopharmaceutical discovery and development; laboratory apparatus and instruments for research on biomaterials adapted and used for printing three-dimensional objects for the creation of prosthetic limbs and grafts; replacement parts and fittings for all the aforesaid goods; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment;Three-dimensional (3D) printers (3D printers); three-dimensional (3D) bioprinters (3D bioprinters); computerized equipment for the generation of three-dimensional shaped parts; machines for manufacturing three dimensional models, namely, computer-aided modeling devices; machines for manufacturing three dimensional (3D) living tissues; machines, namely, three dimensional (3D) bioprinter for the printing of living tissues; cartridges for containing printing material for use with three dimensional printers; cartridges for containing bioprinting material for use with three dimensional printers; printing cartridges for containing biomaterial for use with three dimensional printers; printing cartridges for containing bioink for use with three dimensional printers;Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs; tissue-regenerative pharmaceutical preparations; biological implants for skin and cartilage; biological skin and cartilage tissue for implantation; cells for medical use; human allograft tissue; living cells for medical use; implants of living tissues for guided tissue regeneration; implants comprising living tissue; implantable materials of living tissue for use in guided tissue regeneration; skin grafts; surgical implants comprised of living tissues; surgical implants of living tissues grown from stem cells; transdermal patches for use to create skin for prosthetic limbs and for skin grafts; living tissues for transplant; antibodies for use to create skin for prosthetic limbs and for skin grafts; stem cells for medical purposes; engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular, and nervous tissue and organs, for medical purposes; biological molecules to assist in the development of tissue; hemostatic gel matrix preparations for treating wounds; natural biomaterials for augmentation of bone, blood and tissue for medical purposes; processed human donor skin for the replacement of soft tissue; pharmaceutical products for tissue regeneration, for tissue repair, for tissue treatment, whether relating to human or animal tissue; pharmaceutical preparations for the treatment of bone diseases, for cartilaginous diseases, for vascular diseases, for neuronal degeneration, for degeneration of tendons and ligaments, for retinal degeneration, for renal degeneration, degeneration of soft tissue, for diseases with abnormal cell proliferation; natural biomaterials for bone filling; natural biomaterials for filling cartilage; stem cells for medical use; surgical implants of living tissue; surgical cloths for wound protection; surgical implants grown from stem cells; biological tissue cultures for medical use, all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment;Stem cells for research purposes; stem cells for scientific purposes; stem cells for research or scientific purposes; stem cells other than for medical or veterinary purposes; hydrogel polymer edible coatings for tablets; lactic acid polymers; aqueous linear polymer gels; photo curable compositions comprising polymers; chemicals for use in polymerisations; engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research; biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment;Medical services, namely, in the field of gene and cellular immunotherapies and transplantation, monitoring and reporting services; medical treatment services; consulting services in the fields of medical treatment and medicines; human cell and tissue banking services; collection and preservation of human blood and cells for medical use, all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment;Surgical, medical, dental apparatus and instruments, including imaging devices, for medical purposes; orthopedic articles, namely, burrs, picks, mirrors, tissue cutters, support bandages, and braces; artificial limbs; artificial surgical implants; bone substitutes for surgical use; fluid injectors for medical purposes; trocars; artificial tissue replacement for restoring, maintaining and /or improving the function of diseased or damaged human or animal tissue; synthetic implants and transplants and synthetic modified implants and transplants, tissue, cells and/or molecules for replacing and/or for supporting the function of missing or damaged body parts; synthetic hard and soft tissue, in particular synthetic bone for transplantation purposes, synthetic bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement; synthetic modified implants and transplants with endogenous material, tissue, cells or molecules for replacement and/or for supporting the function of missing or damaged body parts, all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment;BIOTHERAPEUTICS;Technical research in the fields of biomimetics, biomaterials, material adaptation, 3D bioprinting and tissue engineering; research and development of medical devices; research in the field of nanotechnology and nanomaterials; synthetic biology research; robotics research; bioengineering research; nanotherapeutics research; 3D bioprinting research; tissue engineering research; research and development of 3D technology and processes; development of rapid prototyping equipment; technical consultancy relating to rapid prototyping; scientific research consulting in the fields of three-dimensional printing; scientific services relating to the isolation and cultivation of human tissues and cells; scientific and medical research and development in the field of bio-printing; scientific and medical research and development in the field of tissue manufacturing; development and culture of artificial tissues and cells (tissue engineering); tissue engineering services; industrial analysis and research services in the field of tissue engineering research in the fields of regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals, research and testing services in the fields of regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals; research and development of new products for others in the fields of regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals; design and development of computer hardware and software, all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment;

AUREGEN BIOTHERAPEUTICS

3D printing services for others; Custom 3D printing services; renting of 3D printers; creation of customized three-dimensional shaped parts using rapid prototyping equipment; 3D bioprinting for others; Bioprinting for others; Research in the field of three-dimensional (3D) printing in the nature of bioprinting for others; Technical consultancy in the field of rapid prototype fabrication of new products for others (44(e) basis);Laboratory apparatus for fabrication of three-dimensional tissues and organs; Biochips for the production of three-dimensional living tissues and organs for research or scientific purposes; bioreactor for cell culturing; bioreactors for laboratory use; bioreactors for research use; cell culture apparatus for laboratory use, namely, cell culture dishes, tissue culture flasks; Nonmedical combination imaging device incorporating a 3D printer for use in research on biomaterials for the creation of prosthetic limbs and grafts; Laboratory apparatus and instruments incorporating a 3D printer for use in research on biomaterials for the creation of prosthetic limbs and grafts; print heads for inkjet printers; Scientific research and laboratory apparatus and instruments incorporating a 3D printer for research on biomaterials for the creation of prosthetic limbs and grafts in the field of cytology; Laboratory apparatus and instruments incorporating a 3D printer for research on biomaterials for the creation of prosthetic limbs and grafts for use in biopharmaceutical discovery and development; Laboratory apparatus and instruments incorporating a 3D printer for research on biomaterials for the creation of prosthetic limbs and grafts; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment (44(e) basis);Three-dimensional (3D) printers; three-dimensional (3D) bioprinters; Machines in the nature of computerized equipment for the generation of three-dimensional shaped parts; machines for manufacturing three dimensional models, namely, computer-aided modeling devices; machines for manufacturing three dimensional (3D) living tissues; machines, namely, three dimensional (3D) bioprinter for the printing of living tissues; cartridges for containing printing material for use with three dimensional printers, sold empty; cartridges for containing bioprinting material for use with three dimensional printers, sold empty; printing cartridges for containing biomaterial for use with three dimensional printers, sold empty; printing cartridges for containing bioink for use with three dimensional printers, sold empty; 3D printers incorporating an imaging device for use in research on biomaterials for the creation of prosthetic limbs and grafts; Combination 3D printers incorporating laboratory apparatus for use in research on biomaterials for the creation of prosthetic limbs and grafts; Combination 3D printers incorporating a scientific research and laboratory apparatus and instruments for research on biomaterials for the creation of prosthetic limbs and grafts in the field of cytology (44(e) basis);Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; Medical preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs for medical use; tissue-regenerative pharmaceutical preparations; Biological bone, skin tissue intended for subsequent implantation for skin and cartilage; biological skin and cartilage tissue intended for subsequent implantation; cells for medical use; human allograft tissue; living cells for medical use; Surgical implants comprised of living tissues for guided tissue regeneration; implants comprising living tissue; Implants comprised of living tissue for use in guided tissue regeneration; skin grafts; surgical implants comprised of living tissues; surgical implants of living tissues grown from stem cells; transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Implants comprised of living tissues for transplant; antibodies for use to create skin for prosthetic limbs and for skin grafts; stem cells for medical purposes; engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular, and nervous tissue and organs, for medical purposes; biological molecules to assist in the development of tissue for medical purposes; hemostatic gel matrix preparations for treating wounds; natural biomaterials for augmentation of bone, blood and tissue for medical purposes; processed human donor skin for the replacement of soft tissue; pharmaceutical products for tissue regeneration, for tissue repair, for tissue treatment, whether relating to human or animal tissue; pharmaceutical preparations for the treatment of bone diseases, for cartilaginous diseases, for vascular diseases, for neuronal degeneration, for degeneration of tendons and ligaments, for retinal degeneration, for renal degeneration, degeneration of soft tissue, for diseases with abnormal cell proliferation; natural biomaterials for bone filling for medical purposes; natural biomaterials for filling cartilage for medical purposes; stem cells for medical use; surgical implants of living tissue; surgical cloths for wound protection; surgical implants grown from stem cells and comprised of living tissue; biological tissue cultures for medical use, all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment; Cartridges containing printing material for use with three dimensional printers, filled with natural biomaterials for augmentation of bone and tissue for medical purposes; Cartridges for use with three dimensional printers filled bioprinting material in the nature of living tissue for medical purposes; printing cartridges for use with three dimensional printers, containing bioink in the nature of living tissue for medical purposes (44(e) basis);Stem cells for research purposes; stem cells for scientific purposes; stem cells for research or scientific purposes; stem cells other than for medical or veterinary purposes; hydrogel polymer edible coatings for tablets; lactic acid polymers for in manufacturing, for use in the manufacture of capsules for pharmaceuticals; aqueous linear polymer gels for in manufacturing, for use in the manufacture of capsules for pharmaceuticals; Chemical preparations in the nature of photo curable resin compositions comprising polymers for scientific purposes; chemicals for use in polymerisations; engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research; biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue for research and scientific purposes; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment (44(e) basis);Medical services, namely, in the field of gene and cellular immunotherapies and transplantation; Medical diagnostic monitoring and reporting of testing services; human cell and tissue banking services; collection and preservation of human blood and cells for medical use; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment (44(e) basis); medical treatment services; consulting services in the fields of medical treatment and medicines; consulting services in the fields of medical treatment and medicines; medical services, namely, plastic surgery and microsurgery, in particular reshaping noses (rhinoplasty) for either cosmetic or reconstructive purposes (1(b) basis);Surgical apparatus and instruments, including imaging devices, for medical purposes; Medical, dental apparatus and instruments, including imaging devices, for medical purposes, for use in surgery; orthopedic articles, namely, burrs, picks, mirrors, tissue cutters, support bandages, and braces; artificial limbs; Surgical implants comprised of artificial material; bone substitutes for surgical use; fluid injectors for medical purposes; trocars; Artificial tissue for replacement and/or restoring, maintaining and/or improving the function of diseased or damaged human or animal tissue; Surgical synthetic implants and transplants and synthetic modified implants and transplants, tissue, cells and/or molecules made of synthetic materials for replacing and/or for supporting the function of missing or damaged body parts; synthetic hard and soft tissue, in particular synthetic bone for transplantation purposes, synthetic bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement; Surgical synthetic modified implants and transplants with endogenous material, tissue, cells or molecules made of synthetic materials for replacement and/or for supporting the function of missing or damaged body parts, all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment (44(e) basis);BIOTHERAPEUTICS;Technical research in the fields of biomimetics, biomaterials, material adaptation, 3D bioprinting and tissue engineering; research and development of medical devices; research in the field of nanotechnology and nanomaterials; synthetic biology research; robotics research; bioengineering research; nanotherapeutics research; Biological research in the field of three-dimensional (3D) bioprinting; tissue engineering research; research and development of 3D technology and processes; development of rapid prototyping equipment; scientific research consulting in the fields of three-dimensional printing; scientific services relating to the isolation and cultivation of human tissues and cells; scientific and medical research and development in the field of bio-printing; scientific and medical research and development in the field of tissue manufacturing; Tissue engineering in the nature of development and culture of artificial tissues and cells; tissue engineering services for scientific and research purposes; Scientific and medical research and analysis services in the field of tissue engineering research, regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals; Scientific research and material testing services in the fields of regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals; research and development of new products for others in the fields of regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals; Autologous and allogeneic tissue engineering for scientific and research purposes; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment (44(e) basis);